Literature DB >> 17478055

Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.

V W S Kung1, R Hassam, A J Morton, S Jones.   

Abstract

The striatum is critically important in motor, cognitive and emotional functions, as highlighted in neurological disorders such as Huntington's disease (HD) where these functions are compromised. The R6/2 mouse model of HD shows progressive motor and cognitive impairments and alterations in striatal dopamine and glutamate release. To determine whether or not dopamine-dependent neuronal plasticity is also altered in the dorsolateral striatum of R6/2 mice, we compared long term potentiation (LTP) and long term depression (LTD) in striatal slices from R6/2 mice with that seen in slices from wild type (WT) mice. In adult WT mice (aged 8-19 weeks), frequency-dependent bidirectional plasticity was observed. High frequency stimulation (four 0.5 s trains at 100 Hz, inter-train interval 10 s) induced LTP (134+/-5% of baseline), while low frequency stimulation (4 Hz for 15 min) induced LTD (80+/-5% of baseline). LTP and LTD were significantly blocked by the N-methyl-D-aspartic acid (NMDA) receptor antagonist D(-)-2-amino-5-phosphonopentanoic acid (D-AP5) (to 93+/-6% and 103+/-8% of baseline respectively), indicating that they are both dependent on NMDA glutamate receptor activation. LTP was significantly blocked by the dopamine D1 receptor antagonist R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH-23390) (98+/-8% of baseline), indicating that LTP is dependent on activation of dopamine D(1)-type receptors, whereas LTD was not significantly different (90+/-7%). In adult R6/2 mice (aged 8-19 weeks), LTP was significantly reduced (to 110+/-4% of baseline), while LTD was not significantly different from that seen in WT mice (85+/-6%). These data show that R6/2 mice have impaired dopamine-dependent neuronal plasticity in the striatum. As dopamine-dependent plasticity is a proposed model of striatum-based motor and cognitive functions, this impairment could contribute to deficits seen in R6/2 mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478055     DOI: 10.1016/j.neuroscience.2007.03.036

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  24 in total

1.  Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease.

Authors:  Glenn M Dallérac; Damian M Cummings; Mark C Hirst; Austen J Milnerwood; Kerry P S J Murphy
Journal:  Neuromolecular Med       Date:  2016-01-18       Impact factor: 3.843

Review 2.  Brain networks in Huntington disease.

Authors:  David Eidelberg; D James Surmeier
Journal:  J Clin Invest       Date:  2011-02-01       Impact factor: 14.808

3.  Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice.

Authors:  Danielle A Simmons; Christopher S Rex; Linda Palmer; Vijay Pandyarajan; Vadim Fedulov; Christine M Gall; Gary Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-05       Impact factor: 11.205

4.  Impaired TrkB receptor signaling underlies corticostriatal dysfunction in Huntington's disease.

Authors:  Joshua L Plotkin; Michelle Day; Jayms D Peterson; Zhong Xie; Geraldine J Kress; Igor Rafalovich; Jyothisri Kondapalli; Tracy S Gertler; Marc Flajolet; Paul Greengard; Mihaela Stavarache; Michael G Kaplitt; Jim Rosinski; C Savio Chan; D James Surmeier
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

5.  Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.

Authors:  Alipi V Naydenov; Marja D Sepers; Katie Swinney; Lynn A Raymond; Richard D Palmiter; Nephi Stella
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

6.  CIQ, a positive allosteric modulator of GluN2C/D-containing N-methyl-d-aspartate receptors, rescues striatal synaptic plasticity deficit in a mouse model of Parkinson's disease.

Authors:  Mona Nouhi; Xiaoqun Zhang; Ning Yao; Karima Chergui
Journal:  CNS Neurosci Ther       Date:  2017-12-11       Impact factor: 5.243

Review 7.  Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.

Authors:  L A Raymond; V M André; C Cepeda; C M Gladding; A J Milnerwood; M S Levine
Journal:  Neuroscience       Date:  2011-08-27       Impact factor: 3.590

Review 8.  Dopamine and glutamate in Huntington's disease: A balancing act.

Authors:  Véronique M André; Carlos Cepeda; Michael S Levine
Journal:  CNS Neurosci Ther       Date:  2010-04-08       Impact factor: 5.243

9.  Dysregulated information processing by medium spiny neurons in striatum of freely behaving mouse models of Huntington's disease.

Authors:  Benjamin R Miller; Adam G Walker; Anand S Shah; Scott J Barton; George V Rebec
Journal:  J Neurophysiol       Date:  2008-07-30       Impact factor: 2.714

Review 10.  The role of dopamine in Huntington's disease.

Authors:  Carlos Cepeda; Kerry P S Murphy; Martin Parent; Michael S Levine
Journal:  Prog Brain Res       Date:  2014       Impact factor: 2.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.